Basic Information
RNALocate ID: | RLID-D:11000782 |
RNA Symbol: | hsa-miR-1260a |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-1260a |
RNA ID: | miRBase:MIMAT0005911 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002778 | Nucleolus | HeLa cells | 23940654 |
RLID:11004332 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11004333 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000229 | Exosome | Epithelial cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-1260a | Multiple sclerosis chronic progressive | MNDR-E-MI-07751 |
MNDR | hsa-miR-1260a | Medulloblastoma | MNDR-E-MI-07752 |
MNDR | hsa-miR-1260a | Estrogen-receptor positive breast cancer | MNDR-E-MI-07753 |
MNDR | hsa-miR-1260a | Estrogen-receptor negative breast cancer | MNDR-E-MI-07754 |
MNDR | hsa-miR-1260a | Progesterone-receptor positive breast cancer | MNDR-E-MI-07755 |
MNDR | hsa-miR-1260a | Progesterone-receptor negative breast cancer | MNDR-E-MI-07756 |
MNDR | hsa-miR-1260a | Her2-receptor positive breast cancer | MNDR-E-MI-07757 |
MNDR | hsa-miR-1260a | Gastric cancer | MNDR-E-MI-07758 |
MNDR | hsa-miR-1260a | Alzheimer disease | MNDR-E-MI-07759 |
MNDR | hsa-miR-1260a | Intracranial aneurysm | MNDR-E-MI-07760 |
MNDR | hsa-miR-1260a | Cardiovascular disease | MNDR-E-MI-07761 |
MNDR | hsa-miR-1260a | Kawasaki disease | MNDR-E-MI-07762 |
MNDR | hsa-miR-1260a | Parkinson disease | MNDR-E-MI-07763 |
MNDR | hsa-miR-1260a | Machado-joseph disease | MNDR-E-MI-07764 |
MNDR | hsa-miR-1260a | Breast cancer | MNDR-E-MI-07765 |
MNDR | hsa-miR-1260a | Pancreatic cancer | MNDR-E-MI-07766 |
MNDR | hsa-mir-1260a | Melanoma | MNDR-E-MI-07767 |
MNDR | hsa-miR-1260a | Nephroblastoma | MNDR-E-MI-07768 |
MNDR | hsa-miR-1260a | Colon adenocarcinoma | MNDR-E-MI-07769 |
MNDR | hsa-miR-1260a | Multiple sclerosis relapsing-remitting | MNDR-E-MI-07770 |
MNDR | hsa-miR-1260a | Familial ovarian cancer | MNDR-E-MI-07771 |
MNDR | hsa-miR-1260a | Glioblastoma | MNDR-E-MI-07772 |
MNDR | hsa-miR-1260a | Astrocytoma | MNDR-E-MI-07773 |
MNDR | hsa-miR-1260a | Glioma | MNDR-E-MI-07774 |
MNDR | hsa-miR-1260a | Osteosarcoma | MNDR-E-MI-07775 |
MNDR | hsa-miR-1260a | Liver cancer | MNDR-E-MI-07776 |
MNDR | hsa-miR-1260a | Lung adenocarcinoma | MNDR-E-MI-07777 |
MNDR | hsa-miR-1260a | Myasthenia gravis autoimmune experimental | MNDR-E-MI-07778 |
MNDR | hsa-miR-1260a | Biliary tract cancer | MNDR-E-MI-07779 |
MNDR | hsa-miR-1260a | Cholangiocarcinoma | MNDR-E-MI-07780 |
MNDR | hsa-miR-1260a | Esophageal cancer | MNDR-E-MI-07781 |
MNDR | hsa-miR-1260a | Lung small cell carcinoma | MNDR-E-MI-07782 |
MNDR | hsa-miR-1260a | Head and neck squamous cell carcinoma | MNDR-E-MI-07783 |
MNDR | hsa-miR-1260a | Hepatocellular carcinoma | MNDR-E-MI-07784 |
MNDR | hsa-miR-1260a | Familiar ovarian carcinoma | MNDR-E-MI-07785 |
MNDR | hsa-miR-1260a | B-cell lymphoma | MNDR-E-MI-07786 |
MNDR | hsa-miR-1260a | Rheumatoid arthritis | MNDR-E-MI-07787 |
MNDR | hsa-miR-1260a | Retinoblastoma | MNDR-E-MI-07788 |
MNDR | hsa-miR-1260a | Neuromyelitis optica | MNDR-E-MI-07789 |
MNDR | hsa-miR-1260a | Colorectal cancer | MNDR-E-MI-07790 |
MNDR | hsa-miR-1260a | Nasopharynx carcinoma | MNDR-E-MI-07791 |
MNDR | hsa-miR-1260a | Nasopharyngeal cancer | MNDR-E-MI-07792 |
MNDR | hsa-miR-1260a | Stroke lacunar | MNDR-E-MI-07793 |
MNDR | hsa-miR-1260a | Breast cancer her3+ negative | MNDR-E-MI-07794 |
TOP